Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUR with Adjuvant Cryoablation for Bladder Cancer
NCT02760953Unknown
- Sponsor
- Huashan Hospital
- Start
- Oct 2017
- Primary completion
- Oct 2018
01
Overview
Randomised, open-label trial (2 arms), sponsored by Huashan Hospital. Primary endpoint: Residual tumor rate. Status: unknown.
Beyond the preview
Go deeper on NCT02760953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760953.